Arkolith/Insider Trading/EYPT/Form 4

Elston George

Chief Financial OfficerEyePoint Pharmaceuticals, Inc. (EYPT) · full profile →Form 4 · filed Sep 22, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 19, 2025Gift(G)20K—$020K
Sep 19, 2025Gift(G)20K—$062K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001429932-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML